Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr495 Inhibitors

Olfr495, an olfactory receptor protein, plays a pivotal role in initiating the neuronal response that underlies the perception of smell. Belonging to the G-protein-coupled receptor (GPCR) family, Olfr495 shares a structural framework with neurotransmitter and hormone receptors, characterized by a 7-transmembrane domain structure arising from single coding-exon genes. This large family of olfactory receptor genes constitutes the most extensive in the genome, and the nomenclature assigned to them is organism-specific. In the case of Olfr495, its role involves the recognition and G protein-mediated transduction of odorant signals within the olfactory system. The function of Olfr495 hinges on its ability to interact with odorant molecules, initiating a complex cascade of events that lead to the neuronal response associated with perceiving specific smells. As a GPCR, Olfr495 relies on G-protein-mediated transduction to relay signals, ultimately shaping the olfactory experience. The 7-transmembrane domain structure is integral to this process, allowing Olfr495 to undergo conformational changes upon ligand binding and subsequent activation. This activation triggers downstream signaling events that culminate in the perception of a particular odor.

In the context of inhibition, various chemical agents can modulate Olfr495 either directly or indirectly. Direct inhibitors, such as MEK inhibitors like U0126 or p38 MAPK inhibitors like SB203580, act on specific components of signaling pathways associated with Olfr495. These chemicals disrupt key nodes in the MAPK pathway, influencing downstream elements involved in olfactory signal transduction. Indirect inhibitors, like calcium channel blockers (e.g., Nifedipine) or SERCA inhibitors (e.g., Thapsigargin), impact cellular processes by altering intracellular calcium levels. Such changes may indirectly affect Olfr495 by disrupting G-protein-mediated transduction, thereby influencing the neuronal response to odorant signals. These inhibitory mechanisms highlight the intricate interplay between Olfr495 and various signaling pathways. The precise modulation of these pathways by different classes of inhibitors underscores the complexity of olfactory signal transduction. Whether directly targeting components of the GPCR signaling cascade or indirectly influencing cellular processes, these chemicals provide valuable insights into the regulatory mechanisms governing Olfr495. Understanding these inhibitory interactions contributes to unraveling the intricate molecular processes that govern olfactory perception, shedding light on potential avenues for further research and exploration in the realm of olfactory receptor function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Amiloride

2609-46-3sc-337527
1 g
$296.00
7
(1)

Amiloride, a potassium-sparing diuretic, may indirectly inhibit Olfr495 by modulating intracellular calcium levels. Its interference with calcium signaling pathways could impact neuronal responses involved in olfactory signal transduction.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126, a MEK inhibitor, directly inhibits the MAPK pathway. By disrupting this pathway, it may influence downstream elements affecting Olfr495, potentially altering G-protein-coupled receptor signaling and impacting olfactory perception.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Pertussis toxin inhibits G-protein signaling. Olfr495, being a GPCR, may be indirectly affected, as pertussis toxin disrupts G-protein-mediated transduction. This interference could alter the neuronal response to odorant signals in the olfactory system.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, may indirectly influence Olfr495 by inhibiting the PI3K-Akt pathway. Modulating this pathway could impact cellular processes associated with olfactory signal transduction, potentially affecting the perception of odors.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Nifedipine, a calcium channel blocker, could indirectly impact Olfr495 by modulating intracellular calcium levels. Changes in calcium signaling may affect G-protein-mediated transduction and alter the neuronal response to odorant molecules, impacting olfactory perception.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580, a p38 MAPK inhibitor, directly targets the MAPK pathway. Inhibition of this pathway may affect downstream elements involved in olfactory signal transduction, potentially influencing Olfr495 and altering the perception of odors in the olfactory system.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, could indirectly influence Olfr495 by disrupting the PI3K-Akt pathway. Modulating this pathway may impact cellular processes associated with olfactory signal transduction, potentially affecting the perception of odors.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin, a SERCA inhibitor, may indirectly inhibit Olfr495 by disrupting calcium homeostasis. Changes in intracellular calcium levels could influence G-protein-mediated transduction, altering the neuronal response to odorant signals and impacting olfactory perception.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

KN-93, a CaMKII inhibitor, may indirectly affect Olfr495 by modulating calcium/calmodulin-dependent signaling pathways. Disruption of these pathways could impact G-protein-coupled receptor function, potentially altering the neuronal response to odorant signals in the olfactory system.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

GF109203X, a PKC inhibitor, may indirectly influence Olfr495 by modulating PKC-mediated signaling pathways. Disruption of these pathways could impact G-protein-coupled receptor function, potentially altering the neuronal response to odorant signals in the olfactory system.